United States
Germany
Japan
United Kingdom
China
A humanized monoclonal antibody against PDL1 expressed in CHO cells according to Tecentriq sequence
| Applications | FC |
| Reactivities | Human |
Products
A humanized monoclonal antibody against PDL1 expressed in CHO cells according to Avelumab sequence
| Applications | FC |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) A humanized monoclonal antibody against PDL1 expressed in CHO cells according to Tecentriq sequence
| Applications | FC |
| Reactivities | Human |
Carrier-free (BSA/glycerol-free) A humanized monoclonal antibody against PDL1 expressed in CHO cells according to Avelumab sequence
| Applications | FC |
| Reactivities | Human |
CN¥ 3,990.00
2周
A humanized monoclonal antibody against PDL1 expressed in CHO cells according to Tecentriq sequence, HRP conjugated
| Applications | FC |
| Reactivities | Human |
CN¥ 3,990.00
2周
A humanized monoclonal antibody against PDL1 expressed in CHO cells according to Avelumab sequence, HRP conjugated
| Applications | FC |
| Reactivities | Human |
CN¥ 3,990.00
2周
A humanized monoclonal antibody against PDL1 expressed in CHO cells according to Tecentriq sequence, Biotinylated
| Applications | FC |
| Reactivities | Human |
CN¥ 3,990.00
2周
A humanized monoclonal antibody against PDL1 expressed in CHO cells according to Avelumab sequence, Biotinylated
| Applications | FC |
| Reactivities | Human |
A humanized monoclonal antibody against PDL1 expressed in CHO cells according to Tecentriq sequence
| Applications | FC |
| Reactivities | Human |
A humanized monoclonal antibody against PDL1 expressed in CHO cells according to Avelumab sequence
| Applications | FC |
| Reactivities | Human |
Topoisomerase I (TOP1) human polyclonal antibody, Purified
| Applications | ELISA, ID, WB |
| Reactivities | Human |
TRIM21 human polyclonal antibody, Purified
| Applications | ELISA, ID |
| Reactivities | Human |
